CAD & CAM Prospering Dental Crowns & Bridges Market

San Francisco, California, May 17, 2017 : Increasing incidences of oral diseases and introduction of new technologies such as CAD & CAM will keep the global dental and crowns and bridges market in good stead in the near future, according to a study by TMR Research. The study, titled “Dental Crowns and Bridges Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017–2025,” also credits the rising number of diabetic patients for the prosperity of the market for dental crowns and bridges. The study has been prepared to serve as a reliable business document for audiences such as dental implants and prosthetics manufacturers, distributors of dental crowns and bridges, research and consulting firms, dental hospitals and clinics, dental practitioners, and laboratory technicians.

All factors that may influence the demand in the global dental crowns and bridges market have been analyzed in the report, and scenario of the market until 2025 has been estimated. One of the key aspect of the report is company profiles section, wherein several market leaders have been studied for their product portfolio, share of the pie, and recent strategic developments.

According to the findings of the report, oral health problems are fairly common among people of all ages, but with the availability of cost-effective long-term solutions, patients seldom hesitate in investing in the treatment. Increasing prevalence of diabetes, in which tooth loss is frequent, is another key factor favoring the global dental crowns and bridges market. In addition to that, new technologies such as CAD/CAM, which is used to treat critical oral health issues such as full mouth reconstruction, bridges, and inlays, will keep the demand flowing in the global dental crowns and bridges market. On the other hand, lack of consumer awareness, limited availability of dentists, and the lack of reimbursement policies are a few factors that will hinder the market from achieving its true potential. The TMR Research report has also detected some trends of the dental crowns and bridges market such as new product launches and the popularity of medical tourism in Asia Pacific.

Based on material, the global dental crowns and bridges market can be segmented into ceramic and metal. Product-wise, the market can be categorized into crowns and bridges. Geographically, the report takes stock of the potential of several regions including Asia Pacific, North America, Europe, and the Middle East and Africa.

Though there are plenty of opportunities in the global dental crowns and bridges market, the presence of a large number of global and regional players has intensified the competitive landscape. In this scenario, product innovation and mergers and acquisition is turning into the most logical strategy for the leading vendors in this market. 3M, DENTSPLY, Nobel Biocare Services, Zimmer-Biomet, Ivoclar Vivadent, and Straumann are some of the prominent companies operating in the global dental crowns and bridges market.

Ebola Cases Resurfacing in Africa, notes WHO

Two patients were confirmed with Ebola virus over the weekend by the World Health Organization (WHO), and both hailed from the Democratic Republic of the Congo (DRC). These two cases do not include three deaths and 17 other hemorrhagic fever cases reported recently in the country. Overall, the WHO is investigating 125 people who may have been subjected to Ebola-Zaire outbreak, as per the news report from Reuters.

Ebola virus remains predominant in Africa, with this being the seventh outbreak in DRC alone. The first instance was in 1976 while the most recent was in 2014, which claimed 49 causalities. The period of 2013 to 2016 had Ebola at its zenith in West Africa.

Less than a Month from the First Symptoms to Death

Out of the three cases for which the WHO has provided details on, one of the patient showed symptoms on April 22 and died inside a fortnight after arrival at a Likati health zone in Bas Uele province, which about two to three hour drive from DRC’s largest city. The man, first reported to be aged 45 and then updated for the age 39, experienced blood in his urine, nose-bleeding, bloody vomiting, and diarrhea. A companion of this patient is currently symptomatic, while the person who drove the two to the facility is now dead.

Lack of Clarity on the Use of Emergency Vaccine

Merck’s rVSV-ZEBOV has shown signs of protection against Ebola-Zaire and was approved for emergency use. Although nearly 300,000 doses of the vaccine are now available, it remains unclear whether the medication was used over these subjects. WHO Africa states that the complete extent of Ebola virus outbreak in 2017 is not yet known, and does not recommend any restriction on travelers from entering DRC.

Dermatology Diagnostic Devices & Therapeutics Demand to Rise by 2025

San Francisco, California, May 16, 2017: The global market for dermatology devices and therapeutics is expected to gain from the rising global geriatrics population, states TMR Research in a research report. The report is titled, “Dermatology Diagnostic Devices and Therapeutics Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025.”

The global market for dermatology diagnostic devices and therapeutics is gaining prominence owing to rising prevalence of various skin disorders and diseases. The growth trail of the market is projected to be decided by the growing pool of geriatric people, persistence of chronic ailments, and patent expiration. Factors such as swelling activities and favorable government initiatives in order to spread awareness about precarious skin disorders.

The fact that is likely to have a substantial impact on the global dermatology diagnostic devices and therapeutics market is the rise in the global geriatric population. As aging skin is comparatively more prone to different skin disorders such as invasive melanoma and skin cancer among others. Therefore, the use of dermatology therapeutics and diagnostic devices by old aged people is anticipated to augment the growth of the global market in the coming years.

High use of cosmetics, changing lifestyles, and rising pollution has also led a rise in the prevalence of psoriasis and acne, thus in turn having a positive effect on the progress of the global dermatology diagnostic devices and therapeutics market. Moreover, mounting expenses on healthcare services and the introduction of improved and advanced dermatology therapeutics and diagnostic devices has further pushed the market towards path of progress.

Region-wise, the global dermatology devices and therapeutics market has been classified into Latin America, North America, Europe, Asia Pacific, the Middle East and Africa, and the Rest of the world. Amongst these, North America is likely to lead the global market owing to enhanced awareness regarding skin disorders and diseases in the region. Exceptional access to healthcare supportive reimbursement policies is further expected to enhance the growth of the market in the coming years. A well-structured health sector is another factor having a constructive influence on the market. Europe will be closely trailing North America and Asia Pacific will be observed as crucial emerging market.

Many top-drawer companies are striving to integrate several technologies used for the development of diagnostic devices into tablets and smartphones in order to improve the diagnostics rate. Some of the leading companies in the market are Michelson Diagnostics Ltd., LEO Pharma A/S, Galderma S.A., Novartis International AG, Cutera, Inc., Astellas Pharma, Inc., Agfa-Gevaert N.V., and Valeant Pharmaceuticals International, Inc.

Growing Emphasis on Advanced Therapeutics to Encourage Growth of Brain Disease Market

San Francisco, California, May 16, 2017: A new research report by TMR Research offers a detailed analysis of the global brain disease market and highlights the key aspects that are expected to influence the growth of the market in the near future. The research study, titled “Brain Disease Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” presents insights into the market segments and the competitive landscape. In addition to this, the limitations and challenges that are being faced by the leading players have been addressed in the scope of the research study.

The high rate of development of the healthcare infrastructure and the rising focus of key players on improving their drug pipeline and therapeutics are the key factors that are anticipated to encourage the overall growth of the market in the near future. In addition, the increasing reimbursement policies and the availability of advanced therapeutics for brain disorders are projected to supplement the market’s growth in the near future. On the flip side, the high cost of treatments and the lack of awareness among consumers in several developing economies are projected to hamper the growth of the global brain disease market throughout the forecast period.

Nevertheless, the increasing focus of the leading players to introduce effective and advanced treatments are expected to bolster global market in the near future. The global market for brain diseases has been classified on the basis of type and treatments. The expansion of the product segment and the emergence of new therapeutics are likely to contribute extensively towards the market’s growth in the near future. The research study offers a detailed overview of the key segmentation and presents insights into the expected statistics of the each segment included in the study.

From a regional perspective, North America is anticipated to witness a high growth throughout the forecast period and is predicted to hold a major share of the market. Europe is estimated to follow North America in the coming years. The rapid growth of this region can be attributed to the rising cases of neurological disorders and the growing demand for effective and technologically advanced equipment. On the other hand, Asia Pacific is projected to register a healthy growth in the coming years, thanks to the rising number of government initiatives to develop healthcare infrastructure. Moreover, the growing awareness among consumers concerning several brain disorders is likely to accelerate the growth of the market in the near future.

Some of the leading players operating in the brain disease market across the globe are F. Hoffmann-La Roche Ltd., AstraZeneca plc, Medtronic, Inc., Boston Scientific Corporation, Omeros Corporation, and Sapiens Neuro. These players are making notable efforts to enhance their market presence by introducing new drugs and therapeutics. In addition, the anticipated entry of new players is predicted to accelerate the growth of the global brain disease market in the next few years.